|
|
Found results for
patents
1.
|
PREPARATION METHOD FOR BIAPENEM ACTIVE INGREDIENT
| Application Number |
CN2020139134 |
| Publication Number |
2022/036975 |
| Status |
In Force |
| Filing Date |
2020-12-24 |
| Publication Date |
2022-02-24 |
| Owner |
- SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD. (China)
- XINXIANG HAIBIN PHARMACEUTICAL CO., LTD. (China)
- JOINCARE HAIBIN PHARMACEUTICAL CO., LTD. (China)
|
| Inventor |
- Luo, Wenjun
- Lin, Nanqi
- Wang, Dong
- Hu, Jinjun
- Wang, Xiaohua
- Zheng, Chunlian
- Ou, Jun
- Zhou, Yueguang
- Huang, Jintian
- Long, Lisong
|
Abstract
A preparation method for a biapenem active ingredient, comprising: 1) dissolving crude biapenem in water to prepare an aqueous solution; 2) adding activated carbon, stirring for decolorization, filtering, and cooling the filtrate for use; 3) adding the filtrate dropwise in a pre-cooled mixed solvent of acetone and ethanol, and crystallizing; 4) growing crystals; and 5) separating, washing, and drying the precipitated crystals to obtain a biapenem active ingredient.
IPC Classes ?
- C07D 519/06 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or containing at least one condensed beta-lactam ring system, provided for by groups , or , e.g. a penem or a cepham system
|
2.
|
PREPARATION METHOD FOR MEROPENEM KEY INTERMEDIATE N-TRIMETHYLSILYLIMIDAZOLE
| Application Number |
CN2020139140 |
| Publication Number |
2022/007347 |
| Status |
In Force |
| Filing Date |
2020-12-24 |
| Publication Date |
2022-01-13 |
| Owner |
- XINXIANG HAIBIN PHARMACEUTICAL CO., LTD. (China)
- SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD. (China)
- JOINCARE HAIBIN PHARMACEUTICAL CO., LTD. (China)
|
| Inventor |
- Liang, Chunsheng
- Qu, Yingying
- Li, Guoxiang
- Gao, Lei
|
Abstract
Provided is a preparation method for N-trimethylsilylimidazole, said method comprising the following steps: 1) under the protection of inert gas, heating imidazole and hexamethyldisilazane to T1, and allowing to react for 1-4 hours; 2) after completing step 1, cooling the reaction system to 30-50°C, evacuating until the vacuum degree is V1, heating to T2, performing distillation at reduced pressure, and collecting a front fraction D1 below 90°C; 3) after completing step 2, heating the reaction system to T3, and collecting a fraction D2 at 95-105°C; after completing step 3, the residual in the reaction system is imidazole.
IPC Classes ?
- C07F 7/10 - Compounds having one or more C—Si linkages containing nitrogen
|
|